One of the major interests of lentiviral vectors (LVs) in gene therapy is their ability to provide long-lasting transgene expression following integration into the host genome. This very property may lead to severe consequences on the cell's physiology owing to viral integration into genes that deregulate the normal cellular transcriptional program. 1 Given the propensity of lentiviral integrases (IN) for active transcriptional units, 2 this represents a non-negligible issue. To circumvent this problem, several groups have evaluated the use of integration-incompetent LVs. [3] [4] [5] [6] [7] [8] Gene expression from these vectors is driven from viral DNA molecules that remain in an episomal form after their entry into the nucleus as 1 or 2 long terminal repeat circles (1-or 2-LTRs, respectively). These episomes are considered as a deadend product in the normal retroviral infection process, but they are a functional substrate for the transcriptional machinery. 9 As they lack an origin of replication, these forms are transient in dividing cells, but remain stably present as episomes in the nucleus of nondividing cells.
Dendritic cells (DCs) are an interesting cell type for gene therapy purposes in light of their master role in the regulation of immune system responses. 10 Although viral infection of DCs can be obtained with lentiviral-derived vectors, the efficacy of this modification is generally low unless high viral inputs are used, because DCs are poorly susceptible to lentiviral infection. 11, 12 We have previously reported that members of the SIV SM /HIV-2 lineage code for a protein, Vpx, are capable of relieving the restriction that is responsible for the poor susceptibility of DCs to lentiviral-mediated modification. 13, 14 Indeed, Vpx augments the efficacy of infection of DCs with integrationcompetent HIV-1 vectors when it is added in trans onto DCs via noninfectious virion-like particles (VLPs) derived from SIV MAC (Vpx-VLPs). In this setting, Vpx promotes the accumulation of viral DNA. Thus, we studied whether similar effects could be observed following modification of DCs with nonintegrative HIV-1-based LV (as depicted in Figure 1a ). Viral integrases (IN) exert several functions during the viral life cycle, ranging from viral particle formation to reverse transcription, and possibly nuclear import. Thus, IN mutants have been divided into two classes according to the specific or pleiotropic defects they impose on mutant viruses (class I or II, respectively 18 ). Mutants in the catalytic site of HIV-1 IN belong to the former. We first constructed an integration defective HIV-1 LV by introducing a single point mutation in the catalytic site of the IN (IN-D116A) . This mutation did not impair viral production and yielded similar infectious titers as compared to wild-type (WT) on HeLa cells, if transduced cells were examined 3 days after infection. However, a sharp loss of green fluorescent protein (GFP)-expressing cells was specifically observed in cells transduced with the IN-D116A mutant when cells were analyzed 11 days after infection (Figure 1b ). This result is not surprising for dividing cells transduced with a nonintegrative LV, as episomal DNA is expected to dilute over cell divisions. Indeed, when the amount of integrated viral DNA was determined by Alu-PCR, none was observed in cells transduced with the IN-D116A mutant ( Figure 1c) .
Next, the ability of normalized WT and IN-D116A mutant LVs was analyzed on primary DCs, macrophages and phytohemagglutinin-stimulated primary blood lymphocytes (PBLs) (Figure 2a ). As we had previously reported, Vpx-VLPs increased by over 10-fold the percentage of GFP-positive DCs following infection with WT HIV-1 vectors. 13 When compared to WT, similar amounts of GFP-expressing cells were also obtained following transduction of DCs with the IN-D116A mutant. Similar to WT, the addition of Vpx-VLPs during IN-D116A LV infection dramatically increased the percentage of transduced cells at all viral inputs tested (by 10-to 20-fold). Accordingly, the percentage of macrophages transduced with the IN-D116A mutant in the presence of Vpx-VLPs increased, although to a lower extent than with DCs (three-to fivefold). 13 As expected in light of the cell-type-specific function of Vpx-VLPs, no effect was observed on stimulated PBLs. Of note, transduction with the IN-D116A mutant virus yielded a substantially lower percentage of transduced cells than WT, even if analysis was carried out 3 days postinfection, that is, prior to substantial dilution of episomal DNA following cell division. We believe that this result can be due to lower transcriptional activity from the episomal DNA in PBLs as opposed to the integrated forms. In addition to their positive effect on the percentage of HIV-1-LVs transduced cells, Vpx-VLPs also increased the median fluorescence intensity of GFPexpressing cells (MFI; Figure 2b ), suggesting that in cells in which they exert a positive effect on viral infection, Vpx-VLPs also act positively on the levels of transgene expressed intracellularly. Modified DCs could be kept in culture for over a month, retaining stable expression of the transgene (Figure 2c ). The advantage of cells transduced in the presence of Vpx-VLPs appeared evident at all time points. 15 LVs were obtained after transfection of 293 T cells with the packaging construct coding gag-pro-pol and all the accessory proteins (Tat, Rev, Vif, Vpr and Nef; not marked for clarity), a miniviral genome bearing a CMV-GFP expression cassette and a construct coding the vesicular stomatitis virus G envelope protein, as described. 15 Noninfectious virion-like particles (referred to as Vpx-VLPs) were similarly produced by transfection of an SIV MAC -based construct coding gag-pro-pol and viral accessory proteins (SIV3 + , Tat, Rev, Vif, Vpx, Vpr and Nef
16
). No viral genome was transfected in this case. We have previously documented that Vpx is the protein responsible for the positive effect of VLPs on the infectivity of incoming HIV-1 LVs. 13 Virions were purified by ultracentrifugation on a double step sucrose cushion (45-25%) and normalized by protein content against standards of known infectivity, or by their infectious titers on HeLa cells, as previously described. 17 Infections were carried out on 10 5 cells for 2 h prior to extensive cell washing. The percentage of transduced GFP-positive cells was determined 3 days after infection by flow cytometry. When indicated, VpxVLPs were provided together with GFP-coding vectors at a multiplicity of infection (MOI) of 2. (b) HeLa cells were transduced with normalized amounts of wild-type (WT) and IN-D116A LVs and analyzed by flow cytometry 3 and 11 days after infection. Control infections were performed in the presence of the reverse-transcriptase inhibitor azidothymidine (AZT) at 10 mg/ml. (c) The presence of integrated provirus was analyzed on transduced cells infected at MOI 10 by Alu-PCR, as described previously. 9 Briefly, the first round of PCR was carried out for 20 cycles with a primer specific for the proviral DNA and a second round specific for Alu sequences in the genome. Fivefold dilutions of the first PCR were then used as the template for a second semiquantitative PCR using two internal primers specific for viral DNA. Amplified products were transferred onto a nylon membrane and hybridized with 32 P-labeled specific probes prior to Phosphorimager quantification. A representative gel is shown here together with a graph presenting data obtained from three independent experiments. CMV, cPPT, central polypurine tract; GFP, green fluorescent protein; p.i., post-infection; RRE, Rev-responsive element; *, self-inactivating.
Vpx in the transduction of DCs by nonintegrative HIV-1 LVs G Berger et al
Finally, the effect of Vpx-VLPs was evaluated by PCR by examining the amount of viral DNA synthesized at 24 h post-infection in a comparison between PBLs, where Vpx-VLPs display no effect, and DCs ( Figure 3 14 Overall, the data presented here indicate that transduction of DCs and, to a lower extent, of macrophages with nonintegrative HIV-1 vectors can be substantially improved using noninfectious SIV MAC VLPs carrying Vpx, thereby extending our previous observations on integrative HIV-1 vectors. 13, 14 The positive effect of Vpx-VLPs on nonintegrative vectors was not totally unexpected in light of our previous findings. 13 Yet, the possibility existed that Vpx required a functional integration complex to exert its function, or that nonintegrative vectors were submitted to defects other than integration that were not sensitive to Vpx.
Although at present we ignore the mechanism by which it exerts its functions, Vpx increases the amount of full-length viral DNA that accumulates during infection of DCs. Two recent reports indicated that the function of Vpx during SIV infection could be exerted through the recruitment of a Cul4-based E3-ubiquitin ligase complex. Indeed, Vpx has been reported to associate with this complex either via an adaptor protein, the DDB1-(damaged DNA-binding protein 1) and CUL4-associated factor 1, or via its structural component, the DDB1. 19, 20 Removal of these factors by small interfering RNAs impaired the functionality of Vpx, suggesting that Vpx may target a cellular factor to this E3-ubiquitin ligase complex and induce its degradation. This function would be required to remove an antiviral restriction present in DCs, thereby exerting a protective effect on viral nucleoprotein complexes. For gene therapy applications, this effect translates in a higher proportion of infectious viral genomes reaching the nucleus and, thus, in a higher fraction of transduced cells in the absence of detectable changes in the physiology of DCs. 13 Safety from the deleterious effects of insertional mutagenesis has become a serious concern in retroviral Figure 2 Virion-like particles (VLPs) carrying Vpx (Vpx-VLPs) increase the efficiency of transduction of dendritic cells (DCs) with an integration-incompetent lentivirus (LV). Primary monocytes were obtained from the blood of healthy donors after ficoll/percoll purification of leukocytes and negative depletion of unwanted cell contaminants (Miltenyi Biotech), as described.
14 Monocytes were differentiated into macrophages or DCs for 4-6 days following incubation with granulocyte-macrophage colony-stimulating factor (GM-CSF; AbCys) or GM-CSF plus interleukin 4 (IL-4; AbCys), respectively. Primary blood lymphocytes (PBLs) were activated 24 h before transduction with phytohemagglutinin (PHA) and IL-2. (a) Transductions were carried out with normalized amount of virions as described in the legend to Vpx in the transduction of DCs by nonintegrative HIV-1 LVs G Berger et al vector-mediated gene therapy applications. Nonintegrative vectors have become an important alternative to their use, as they remove the cause of such effects, that is, integration. However, given that transgene expression from these vectors depends on the presence of episomal DNA, their use is limited to applications in which transgene expression is required either transiently in dividing cells or stably in differentiated nondividing cells. In this respect, DCs as well as macrophages are suitable targets for modification via nonintegrative vectors, as they are differentiated antigen-presenting cells, but display a partial resistance to lentiviral infection and elevated viral inputs are needed to achieve high levels of transduction that may modify the cells' physiology. 11, 12 The protocol described here allows an efficient modification of DCs with nonintegrative and, thus, safer vectors, in the presence of low viral inputs. This property may be important to avoid viral overload of DCs and possible deleterious consequences on the physiology of DCs both ex vivo and in vivo. . Primary blood lymphocytes (PBLs) and DCs transduced with normalized amounts of wild-type (WT) or IN-D116A LVs in the presence or absence of Vpx-VLPs were harvested, lysed and the amount of synthesized viral DNA was determined by semiquantitative PCR using primers that recognize specifically full-length (FL) and episomal (2-LTRs) DNA forms, as described.
14 Briefly, PCRs were carried out on fivefold serial dilution of samples to ensure the linearity of the reaction, amplified products were transferred onto a nylon membrane and hybridized with 32 P-labeled specific probes prior to Phosphorimager quantification. The signals were normalized for those obtained after amplification of actin DNA and with respect to WT. Data obtained from four to five independent experiments are shown here. IN, integrase; LTR, long terminal repeat.
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